Litcius/Paper detail

SO-29 Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset

Valentina Boni, Alexander Drilon, John F. Deeken, Elena Garralda, Hyun Cheol Chung, Ichiro Kinoshita, Do‐Youn Oh, Jyoti D. Patel, Rui‐Hua Xu, Ricarda Norenberg, Nicoletta Brega, L. Dima, David S. Hong, Jordan Berlin

2021Annals of Oncology13 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTrk receptorCancerInternal medicineColorectal cancerOncologyReceptor tyrosine kinaseResponse Evaluation Criteria in Solid TumorsTargeted therapyTropomyosin receptor kinase AGastroenterologyPhases of clinical researchClinical trialReceptorNeurotrophinGastric Cancer Management and OutcomesColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology Research
SO-29 Efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase fusion-positive gastrointestinal cancer: An expanded dataset | Litcius